BioCentury | Sep 11, 2020
Product Development

Loxo’s Bilenker on why reimbursement crisis is creating innovation, access crises: a BioCentury audio interview

...hit -- a commentary. It was really prescient...
BioCentury | Apr 25, 2020
Management Tracks

COVID-19 takes life of former FDA Commissioner Kennedy

COVID-19 has taken the life of Donald Kennedy, former FDA commissioner, Stanford University president, and for decades one of the most important public faces of American science. Kennedy, 88, served as FDA commissioner from 1977...
BioCentury | Nov 16, 2019
Company News

Management tracks: Lonza CEO to step down; plus Arrowhead, Insmed, Inozyme, Yukin, Pfenex, EyePoint, Verseau, Abingworth, CBC, Flagship, Diverse, Theragnostics,

...senior medical development director at Ipsen Group (Euronext:IPN; Pink:IPSEY). Tony Grover has joined diagnostics company Prescient...
BioCentury | Sep 21, 2018
Company News

Prescient, Metabiomics partner for colon cancer diagnostics

...colon. Prescient Medicine Holdings LLC, Hummelstown, Pa. Metabiomics Corp., Aurora, Colo. Business: Diagnostic Elizabeth S. Eaton diagnostic Metabiomics Corp. Prescient...
BioCentury | Apr 20, 2018
Clinical News

Prescient reports 50% ORR in Phase Ib of PTX-200 for breast cancer

...three cases of stable disease. The recommended Phase II dose is 35 mg/m 2 PTX-200. Prescient...
...breast cancer and Phase Ib/II testing to treat acute myelogenous leukemia (AML) and ovarian cancer. Sandi Wong PTX-200 Prescient...
BioCentury | Jan 7, 2008
Finance

Mollified by mid-caps

...Last year, buysiders were anticipating a raft of major M&A deals. And this view looked prescient...
BioCentury | Jan 8, 2007
Strategy

Beyond the land Down Under

...With a big infusion of cash coming in via its prescient investment in Domantis Ltd...
BioCentury | Nov 20, 2006
Strategy

Seeing the future

...strategic decision to wean itself away from biodefense-related products. The decision appears to have been prescient...
BioCentury | Jun 14, 2004
Tools & Techniques

Anxious? Check your mGluRs

...Inc. (NPSP; TSE:NX, Salt Lake City, Utah) and partner AstraZeneca plc (LSE:AZN; AZN, London, U.K.), Prescient NeuroPharma Inc....
BioCentury | Mar 24, 2003
Company News

Senetek management update

...Napa, Calif. Business: Dermatological Hired: Brad Holsworth as CFO, formerly CFO of WideOrbit Inc. and Prescient...
Items per page:
1 - 10 of 28
BioCentury | Sep 11, 2020
Product Development

Loxo’s Bilenker on why reimbursement crisis is creating innovation, access crises: a BioCentury audio interview

...hit -- a commentary. It was really prescient...
BioCentury | Apr 25, 2020
Management Tracks

COVID-19 takes life of former FDA Commissioner Kennedy

COVID-19 has taken the life of Donald Kennedy, former FDA commissioner, Stanford University president, and for decades one of the most important public faces of American science. Kennedy, 88, served as FDA commissioner from 1977...
BioCentury | Nov 16, 2019
Company News

Management tracks: Lonza CEO to step down; plus Arrowhead, Insmed, Inozyme, Yukin, Pfenex, EyePoint, Verseau, Abingworth, CBC, Flagship, Diverse, Theragnostics,

...senior medical development director at Ipsen Group (Euronext:IPN; Pink:IPSEY). Tony Grover has joined diagnostics company Prescient...
BioCentury | Sep 21, 2018
Company News

Prescient, Metabiomics partner for colon cancer diagnostics

...colon. Prescient Medicine Holdings LLC, Hummelstown, Pa. Metabiomics Corp., Aurora, Colo. Business: Diagnostic Elizabeth S. Eaton diagnostic Metabiomics Corp. Prescient...
BioCentury | Apr 20, 2018
Clinical News

Prescient reports 50% ORR in Phase Ib of PTX-200 for breast cancer

...three cases of stable disease. The recommended Phase II dose is 35 mg/m 2 PTX-200. Prescient...
...breast cancer and Phase Ib/II testing to treat acute myelogenous leukemia (AML) and ovarian cancer. Sandi Wong PTX-200 Prescient...
BioCentury | Jan 7, 2008
Finance

Mollified by mid-caps

...Last year, buysiders were anticipating a raft of major M&A deals. And this view looked prescient...
BioCentury | Jan 8, 2007
Strategy

Beyond the land Down Under

...With a big infusion of cash coming in via its prescient investment in Domantis Ltd...
BioCentury | Nov 20, 2006
Strategy

Seeing the future

...strategic decision to wean itself away from biodefense-related products. The decision appears to have been prescient...
BioCentury | Jun 14, 2004
Tools & Techniques

Anxious? Check your mGluRs

...Inc. (NPSP; TSE:NX, Salt Lake City, Utah) and partner AstraZeneca plc (LSE:AZN; AZN, London, U.K.), Prescient NeuroPharma Inc....
BioCentury | Mar 24, 2003
Company News

Senetek management update

...Napa, Calif. Business: Dermatological Hired: Brad Holsworth as CFO, formerly CFO of WideOrbit Inc. and Prescient...
Items per page:
1 - 10 of 28